BC-DN-01 / BioChemics  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BC-DN-01 / BioChemics
NCT01793350: Safety and Efficacy Study of BC-DN-01 in Painful Diabetic Peripheral Neuropathy

Withdrawn
1/2
0
Europe
BC-DN-01 topically applied cream, active ingredient of BC-DN-01 : benfotiamine
BioChemics, Inc., Harrison Clinical Research
Diabetic Neuropathy, Painful
10/14
12/14

Download Options